Gardoni F - Search Results

1

Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies.

Imarisio A, Ferrari E, Pilotto A, Di Luca M, Padovani A, Gardoni F. Imarisio A, et al. Among authors: gardoni f. Neurodegener Dis. 2022;22(1):7-14. doi: 10.1159/000526376. Epub 2022 Aug 8. Neurodegener Dis. 2022. PMID: 35940118

2

Pathophysiological implications of the structural organization of the excitatory synapse.

Cattabeni F, Gardoni F, Di Luca M. Cattabeni F, et al. Among authors: gardoni f. Eur J Pharmacol. 1999 Jun 30;375(1-3):339-47. doi: 10.1016/s0014-2999(99)00299-x. Eur J Pharmacol. 1999. PMID: 10443587 Review.

3

Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors.

Fiorentini C, Gardoni F, Spano P, Di Luca M, Missale C. Fiorentini C, et al. Among authors: gardoni f. J Biol Chem. 2003 May 30;278(22):20196-202. doi: 10.1074/jbc.M213140200. Epub 2003 Mar 19. J Biol Chem. 2003. PMID: 12646556 Free article.

4

CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction.

Gardoni F, Mauceri D, Fiorentini C, Bellone C, Missale C, Cattabeni F, Di Luca M. Gardoni F, et al. J Biol Chem. 2003 Nov 7;278(45):44745-52. doi: 10.1074/jbc.M303576200. Epub 2003 Aug 21. J Biol Chem. 2003. PMID: 12933808 Free article.

5

Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.

Zimmermann M, Gardoni F, Marcello E, Colciaghi F, Borroni B, Padovani A, Cattabeni F, Di Luca M. Zimmermann M, et al. Among authors: gardoni f. J Neurochem. 2004 Sep;90(6):1489-99. doi: 10.1111/j.1471-4159.2004.02680.x. J Neurochem. 2004. PMID: 15341532 Free article.

6

Artificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease.

Di Luca M, Grossi E, Borroni B, Zimmermann M, Marcello E, Colciaghi F, Gardoni F, Intraligi M, Padovani A, Buscema M. Di Luca M, et al. Among authors: gardoni f. J Transl Med. 2005 Jul 27;3:30. doi: 10.1186/1479-5876-3-30. J Transl Med. 2005. PMID: 16048651 Free PMC article.

7

Molecular rationale for the pharmacological treatment of Alzheimer's disease.

Zimmermann M, Gardoni F, Di Luca M. Zimmermann M, et al. Among authors: gardoni f. Drugs Aging. 2005;22 Suppl 1:27-37. doi: 10.2165/00002512-200522001-00003. Drugs Aging. 2005. PMID: 16506440 Review.

8

New targets for pharmacological intervention in the glutamatergic synapse.

Gardoni F, Di Luca M. Gardoni F, et al. Eur J Pharmacol. 2006 Sep 1;545(1):2-10. doi: 10.1016/j.ejphar.2006.06.022. Epub 2006 Jun 15. Eur J Pharmacol. 2006. PMID: 16831414 Review.

9

Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors.

Gardoni F, Polli F, Cattabeni F, Di Luca M. Gardoni F, et al. Eur J Neurosci. 2006 Nov;24(10):2694-704. doi: 10.1111/j.1460-9568.2006.05140.x. Eur J Neurosci. 2006. PMID: 17156196

10

Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity.

Marcello E, Gardoni F, Mauceri D, Romorini S, Jeromin A, Epis R, Borroni B, Cattabeni F, Sala C, Padovani A, Di Luca M. Marcello E, et al. Among authors: gardoni f. J Neurosci. 2007 Feb 14;27(7):1682-91. doi: 10.1523/JNEUROSCI.3439-06.2007. J Neurosci. 2007. PMID: 17301176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters